Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder pa

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder pa

Item
http://www.wikidata.org/entity/Q28238749
Antiglucocorticoid and related treatments for psychosisThe Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-AnalysisIncorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic DiseasesNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewConvergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice.Effects in dogs with behavioural disorders of a commercial nutraceutical diet on stress and neuroendocrine parameters.Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders.Investigational drugs for anxiety in patients with schizophrenia.Anxiety in Patients with Schizophrenia: Epidemiology and Management.Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet.Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.Effect of L-theanine on glutamatergic function in patients with schizophrenia.
P2860

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder pa

Item
http://www.wikidata.org/entity/Q28238749
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@en
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@nl
type
label
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@en
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@nl
prefLabel
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@en
Serum levels of brain-derived ...... nd schizoaffective disorder pa
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P698
P921
P3181
P356
P1433
P1476
Serum levels of brain-derived ...... izoaffective disorder patients
@en
P2093
P304
P31
P3181
P356
10.1097/WNF.0B013E318220D8C6
P407
P433
P478
P50
P577
P698
P921